These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15863817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN, Wasylink S, Epperson CN, McDougle CJ.
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
    Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J.
    Biol Psychiatry; 2006 Feb 01; 59(3):211-5. PubMed ID: 16139813
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.
    J Clin Psychiatry; 2007 Feb 01; 68(2):224-36. PubMed ID: 17335320
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.
    J Clin Psychiatry; 2010 Apr 01; 71(4):451-62. PubMed ID: 20361905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
    Fountoulakis KN, Iacovides A, Siamouli M, Koumaris V, Kaprinis GS.
    Int J Clin Pharmacol Ther; 2006 Sep 01; 44(9):452-3. PubMed ID: 16995335
    [No Abstract] [Full Text] [Related]

  • 14. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking.
    Christensen RC.
    Can J Psychiatry; 2004 Nov 01; 49(11):788-9. PubMed ID: 15633864
    [No Abstract] [Full Text] [Related]

  • 15. Use of olanzapine in anorexia nervosa.
    Menaster M.
    J Clin Psychiatry; 2005 May 01; 66(5):654-5; author reply 655-6. PubMed ID: 15889956
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT.
    Drugs Today (Barc); 2006 Mar 01; 42(3):185-92. PubMed ID: 16628260
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M, Pashinian A, Gil-Ad I, Maayan R, Schneidman M, Fuchs C, Weizman A.
    Am J Psychiatry; 2002 Jun 01; 159(6):1058-60. PubMed ID: 12042201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.